About two dozen virus families are known to infect humans, and the modified protein that Graham’s lab had developed to deal with RSV might be transferable to many of them. Then there was the question of how to deliver the vaccine. Graham knew that Moderna, a biotech startup in Cambridge, Massachusetts, had encoded a modified protein on strips of genetic material known as messenger RNA.
